Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Charnwood

Charnwood is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country and 1 service area.

View Charnwood on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Agricultural Sciences Research & Development

  • Chemical and Physical Determination of chemical and physical properties of pesticide product.

Antibodies

  • Antibody Conjugation Conjugate an enzyme, biotin, or fluorophore to an antibody.
  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.
  • Antibody-Drug Conjugation Improve therapeutic properties of an antibody or drug by joining them together.
  • Immunodetection Use antibodies to identify a protein or antigen.

Bioimaging

  • Confocal/Optical Microscopy Use optical imaging technique to increase optical resolution and contrast of a micrograph.
  • Cryo Electron Microscopy Examine the 3D structure of biological complexes and organelles.
  • Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
  • Mass Spectrometry Imaging Visualize the spatial distribution of molecules, as biomarkers, metabolites, peptides or proteins by their molecular masses
  • Microscopy Use microscopy to analyze surfaces of biological materials and to develop 3D images of biological structures.
Show all 7 in Bioimaging 1 more
  • Scanning Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.

Biomarkers

  • Basic Metabolic Profiling Set up assays that monitor drug metabolite formation after administration of drug to an animal model or patient.
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
  • Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
Show all 27 in Biomarkers 21 more
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Chemotaxis Assays Investigate the in vivo or in vitro movement of cells towards or away from a chemotactic agent.
  • Customized Primary Cell Isolation Plan and execute the isolation of primary cells from a specific biosample.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
  • Endocrine Assays Use biochemical, cell based or in vivo assays to measure the concentration of hormones.
  • Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
  • Fluorescent In Situ Hybridization Use FISH to identify abnormal chromosome structures and to quantify specific DNA sequences.
  • Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
  • Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
  • Immunophenotyping Separate cell types based on their expression of biomarkers or based on their individual and unique expression patterns.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
  • Plaque Assays Determine infectious viral titer using plaque-forming units or purify viral stocks.
  • Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
  • Propidium Iodide FACS Analysis Use DNA staining and flow cytometry to analyze the cell cycle and detect apoptosis or cell proliferation.
  • Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Stem Cell Analysis Assess hematopoietic, neural and mesenchymal cell progenitor proliferation and differentiation.
  • T Cell Epitope Characterization Evaluate the potency and immunodominance of T-cell epitopes within a molecule.
  • TUNEL Assay Detect in situ DNA fragmentation.
  • Wound Healing Assay Use cell-based assays to investigate cell proliferation, cell migration and wound closure.
Show all 294 services 277 more

Cell Culture and Characterization

  • 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
  • Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
  • Cell Culture Culture primary or immortalized cell lines.
  • Cell Line Construction Create new recombinant cell lines to exact specifications.
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
  • Explant Culture Culture cells obtained from a part or parts of an in vivo structure.
Show all 9 in Cell Culture and Characterization 3 more
  • Microsatellite Instability Analysis Compare allelic profiles and detect genomic instability.
  • Recombinant Technology Manipulate genotypes to introduce or modify the expression of specific cell products or physical traits.
  • Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.

Chemical and Compound Analysis

  • API Physical Characteristics Characterize physical and chemical properties of new drug molecules to develop safe, effective, and stable dosage forms.
  • Chemical Stability Measure the stability of small molecules in solution.
  • Chiral Separation Purify therapeutically active isomers of drug candidates.
  • Denaturing High Performance Liquid Chromatography Separate mixtures of denatured and reannealed oligos to identify single nucleotide substitutions, deletions and insertions.
  • Dissolution Profiling Measure release of API from formulation (tablet or capsules) under GMP guidelines.
  • Dynamic Light Scattering Determine the size of particles and extent of molecular aggregation in a suspension.
Show all 32 in Chemical and Compound Analysis 26 more
  • Elemental Impurity Analysis Identify and evaluate the presence of heavy metals in pharmaceuticals.
  • Endotoxin Testing Use standard assays like LAL (Limulus Amebocyte Lysate), rFC (Recombinant Factor C), or MAT (Monocyte Activation Test) to detect and quantify the level of endotoxins in a sample
  • Headspace Gas Chromatography Analyze volatile organic compounds (VOCs) partitioned above the liquid/solid phase of a sample.
  • High Resolution MS Elucidate the sequence and structure of peptides, proteins, biomarkers and organic compounds.
  • Immunoaffinity Chromatography Use antibody-antigen interactions to isolate and concentrate analytes.
  • Isothermal Titration Calorimetry An ITC assay will be established and optimised for the affinity measurement of test substance to target molecule.
  • Liquid Chromatography Separate substances using a mobile and stationary phase.
  • Melting Point Use melting point analysis to characterize compounds based on calorimetry and thermodynamic data.
  • Natural Product Libraries Find microbial, botanical and marine sources of natural products.
  • NMR Methods Use nuclear magnetic resonance spectroscopy to identify drug intermediates.
  • NMR Structure Determine molecular structure, identify chemical impurities and validate sample integrity.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Particle Size Analysis Measure particle size distribution and characterize particle size, porosity and composition.
  • Partition Coefficient Determine lipophilicity (hydrophobicity) of compounds by measuring log P.
  • Photostability Measure drug degradation rates after exposure to various light sources.
  • Process Residual Impurities Detection Measure trace levels of impurities.
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Protein Melting Point Analysis Assess protein stability by Differential Scanning Calorimetry (DSC) or Fluorimetry (Thermofluor) methods.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Scanning and Transmission Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Size Exclusion Chromatography Separate and identify analytes based on their molecular size.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.
  • Solution Nuclear Magnetic Resonance Identify molecular structure or impurities and assess product integrity of solution samples.
  • Structural Chemistry Examine the relationship between protein structure and function.
  • Structure Determination Determine the three-dimensional structure of proteins in the presence or absence of ligands.
  • X-Ray Fluorescence (XRF) Identify and quantify the elemental composition of solid and liquid samples.

Chemistry, Manufacturing and Controls (CMC)

  • Advanced intermediates Sourcing advanced intermediates
  • Bulk Raw Materials Acquire raw materials in large volumes at wholesale pricing.
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Crystallization studies Crystallization studies
  • Formulation Services Assistance when determining the look, texture, fragrance of a product with compatibility with product packaging, knowledge of competitive performance traits and product shelf life.
  • Key Starting Materials Sourcing key starting materials (KSM)
Show all 9 in Chemistry, Manufacturing and Controls (CMC) 3 more
  • Polymorph Screening Screen for unwanted API forms resulting from the drug formulation process.
  • Salt Form Selection Use high-throughput automated arrays to combine APIs with multiple salts and ions to optimize formulation.
  • Thermal Analysis Characterize compounds based on calorimetry and thermodynamic data.

Data Science/Bioinformatics

  • Discovery In Silico Drug Dynamics Develop In Silico model of a drug candidate with a biological system with applications such as Pro-drug Predictions, ADME-PK Due Diligence, Brain-Barrier Permeability Simulation, Drug Absorption Simulation, In Silico...
  • In Silico ADME-PK Consultation Consult with experts for ADME-PK data analysis or predictive modelling design in different in vivo or in vitro states.
  • In Silico ADME-PK Predictions Use computer software to simulate in vivo physiological conditions of animals or humans to predict ADME-PK properties.
  • In Silico Pro-drug Predictions Use computer simulation to assess pro-drug absorption and conversion to predict pharmacokinetic properties.

Discovery Chemistry

  • Activity Prediction Identify possible chemical hits based on the known three-dimensional structure of a protein.
  • Building Blocks Find chemicals used for creating new compound chemotypes and HTS libraries.
  • Certified Standards Find certified standards for assays, tests and services.
  • Compound Docking Identify potential compound hits based on the 3D structure of a target protein.
  • Compound Management Buy, maintain and process compound libraries, natural product libraries and building blocks.
  • Compound Purchase Buy compounds, building blocks or compound libraries.
Show all 30 in Discovery Chemistry 24 more
  • Compound Synthesis Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Custom Building Blocks Find or synthesize mg to kg amounts of chemical building blocks, scaffolds and reactive intermediates.
  • Custom Synthesis Find or synthesize mg to kg amounts of target-specific and target agnostic compounds for HTS and biological screening.
  • Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
  • Fragment Libraries Find fragment libraries for screening against a protein or cellular target.
  • Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
  • HTS Libraries Find targeted and broad collections of chemical compounds for high throughput screening and ADMET applications.
  • In Silico Lead Optimization Use in silico design to enhance the ADME-PK properties of candidate drugs to maximize efficacy and safety.
  • In Silico Metabolite Predictions Conduct in silico assessment of metabolite pharmacokinetic properties and potential exposure effects.
  • Large Scale Purification Purify gram to kilogram amounts of recombinantly-expressed or wild-type proteins.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.
  • Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
  • Method Development and Validation Develop and validate methods for synthesis and scale up of drug candidates.
  • Natural Product Screening Screen large natural product collections for therapeutic activity.
  • Pharmaceutical Research Chemicals Acquire chemicals that are prospective new drug entities.
  • Pharmacophore Modeling Use computer models to identify hits based on structural similarity to known active compounds.
  • QSAR Analysis Develop quantitative structure–activity relationship models for drug design.
  • Stable Isotope Synthesis Label drug candidates with stable isotopes that simplify compound tracking and distribution studies.
  • Structure Activity Relationship (SAR) Analyze the relationship between the structure of a compound and its biological activity.
  • Structure Property Relationship (SPR) Determine the functionality of a compound through the analysis of it's structure.
  • Target-Focused Compound Libraries Find activity-based libraries directed towards a protein or cell signaling target.
  • Time of Flight Mass Cytometry (CyTOF™) Detect and quantify up to 34 different proteins simultaneously on a single-cell level.
  • Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

DNA & RNA

  • qPCR Analysis Measure the accumulation of PCR products in real time.
  • Quantitative RT PCR Use quantitative reverse transcription polymerase chain reaction to measure absolute and relative mRNA abundance.

Drug Development

  • Chemoinformatics Consulting The use of computer and informational techniques applied to a range of problems in the field of chemistry.
  • Medicinal Chemistry Consulting Apply chemistry training to the process of synthesizing new pharmaceuticals.
  • Small Molecule Drug Development Consulting Request consulting services related to small molecule development.
  • Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.

Human Biological Samples

  • 3D InSight™ Liver Microtissues Perform in vitro assessment of islet function for efficacy and toxicity testing.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Cell Permeability and Absorbance Models Cell Permeability and Absorbance Model assay.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
Show all 30 in In Vitro ADME 24 more
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.
  • Reference Standards Find reference standards for assays, tests and services.

In Vitro Assays

  • 3D Cell Microscopy Assay Investigate cellular and subcellular events in three dimensional 3D cultures by using fluorescence microscopy.
  • Annexin V Apoptosis Assay Detect and quantify apoptotic cells based on loss of membrane asymmetry.
  • Antivirals Measure anti-viral activity in biochemical and cell assays.
  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
  • Apoptotic Cell Staining Detect apoptotic cells in culture.
  • Assay Development Construct or create new assays or modify existing ones.
Show all 29 in In Vitro Assays 23 more
  • Biosensor Assays Evaluate biological activity of new compounds, detect toxic metabolites or monitor biomarkers.
  • Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • Cytometric Bead Array (CBA) FACS Analysis Use flow cytometry and antibody-coated beads to simultaneously detect multiple target proteins.
  • Endpoint Dilution Assay (TCID50) Assay Determine the viral titer to induce cell death in half the cell population of an inoculated tissue culture.
  • Glucose Release Assay Determine free glucose levels in biological samples.
  • Glucose Uptake Measure glucose uptake in cultured cells using GLUT4 signaling assays.
  • High Content Screening Analyze whole cells or components of cells with simultaneous readout of several parameters.
  • HTS Assay Development Develop assays to use in high throughput screening.
  • Hydroxyproline Assays Use biochemical, cell based or in vivo assays to quantify hydroxyproline or collagen in a sample.
  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.
  • Invasion Assays Monitor and quantify the ability of cultured cells to permeate real or artificial biological barriers.
  • Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
  • Lipolysis Measure the hydrolysis of triglycerides into glycerol and free fatty acids.
  • Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.
  • Pathway Mapping Define mechanisms of action by analyzing protein pathways affected by drug treatment.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.
  • Reactive Species Assays Use biochemical, cell-based or in vivo assays to detect and evaluate the effects of reactive species.
  • Serine Protease Assay Detect apoptosis by measuring protease activity.
  • Stem Cell Differentiation Microscopy Assay› Elucidate mechanisms of stem cell renewal and differentiation in vitro using fluorescence microscopy.

In Vitro Pharmacology

  • Anaplastic lymphoma kinase (ALK) Assays Use biochemical, cell based or in vivo assays to measure ALK enzyme activity.
  • Aptamer Products Obtain pre-made aptamers for specific target binding.
  • ATP Competitive Study Determine whether or not a compound is competitive with ATP.
  • B-Cell Lymphoma 2 (BCL-2) Assays Use biochemical, cell based or in vivo assays to measure BCL-2 protein activity.
  • Calcium Channel Assays Use biochemical, cell-based or in vivo assays to measure calcium channel activity.
  • Cellular Thermal Shift Assay Use a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies.
Show all 69 in In Vitro Pharmacology 63 more
  • Chloride Channel Assays Use biochemical, cell-based or in vivo assays to measure chloride channel activity.
  • Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
  • Dehydrogenase Assays Measure dehydrogenase activity in biochemical and cell-based assays.
  • Extracellular signal Regulated Kinase Assays Use biochemical, cell based or in vivo assays to measure ERK enzyme activity.
  • Fibroblast Growth Factor Receptor (FGFR) Assays Use biochemical, cell based or in vivo assays to measure FGF receptor activity.
  • G-Protein Coupled Receptor (GPCR) Assays Detect ligand binding, receptor dimerization and downstream signal transduction events.
  • Glucose Transporter Assays Use biochemical, cell-based or in vitro assays to measure glucose transporter activity.
  • High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
  • Histone Acetyltransferase (HAT) Assays Use biochemical, cell-based or in vivo assays to measure histone acetyltransferase activity.
  • Histone Deacetylase (HDAC) Assays Use biochemical, cell-based or in vivo assays to measure histone deacetylase activity.
  • Human BCL Assays Use biochemical, cell-based or in vivo assays to measure BCL activity.
  • Human Epidermal growth factor Receptor (HER) Assays Use biochemical, cell based or in vivo assays to measure HER receptor activity.
  • Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
  • In Vitro Bone Models Measure osteoclast activity and bone formation in human or rat osteoclasts.
  • In Vitro Cardiovascular Models Measure stimulation and inhibition of lipolysis, adipogenesis and endothelial cell migration.
  • In Vitro Diabetes Models Measure insulin stimulation of glucose uptake and metabolism of lipids including cholesterol and triglycerides.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Excitotoxicity Models Use in vitro models to measure therapeutic endpoints associated with excitotoxic pathology.
  • In Vitro Eye Models Measure cytokine production, cell viability, apoptosis and wound healing.
  • In Vitro Fertilization Models Measure oocyte maturation, embryo development in culture and sperm fertilizing ability.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Ion Channels Use fluorometry, electrophysiology and radiometric binding assays to measure ion channel activity.
  • Kinase Assays Measure activity of over 500 kinases in biochemical or cell-based assays.
  • Liposome Immunoassay Use immuno-liposomes for improved signal intensity and detection sensitivity compared to enzyme and fluorescent immunoassays.
  • Mammalian Target of Rapamycin Complex Assays Use biochemical, cell based or in vivo assays to measure mTORC enzyme activity.
  • Methyltransferase Assays Use biochemical, cell-based or in vitro assays to measure methyltransferase activity.
  • Mitogen/Extracellular signal-regulated Kinase (MEK) Assays Use biochemical, cell based or in vivo assays to measure MEK enzyme activity.
  • Mutant B-Raf Assays Use biochemical, cell based or in vivo assays to measure mutant B-Raf enzyme activity.
  • Nitric Oxide Synthase Assays Measure nitric oxide synthase activity by biochemical or cellular assays.
  • Nuclear Receptor Assays Measure nuclear receptor activity in biochemical and cell assays.
  • Nucleoside Transporter Assays Use biochemical, cell-based or in vivo assays to measure nucleoside transporter activity.
  • Oxidase Assays Use biochemical, cell-based or in vivo assays to measure oxidase activity.
  • PARP Assays Use biochemical, cell-based or in vivo assays to measure PARP activity.
  • Peptide Transporter Assays Use biochemical, cell-based or in vivo assays to measure peptide transporter activity.
  • Peroxidase Assays Measure peroxidase activity in bacterial and mammalian cells.
  • Phosphatase Assays Use biochemical, cell-based or in vitro assays to measure phosphatase activity.
  • Phosphatidylinositol 3-Kinase (PI3K) Assays Use biochemical, cell based or in vivo assays to measure PI3K enzyme activity.
  • Phosphodiesterase Assays Measure phosphodiesterase activity in biochemical and cell-based assays.
  • Polymerase Assays Measure polymerase activity in biochemical and cell-based assays.
  • Potassium Channel Assays Use biochemical, cell-based or in vivo assays to measure potassium channel activity.
  • Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
  • Protease Assay Measure protease activity in biochemical and cell-based assays.
  • Protein Kinase B (Akt) Assays Use biochemical, cell based or in vivo assays to measure Akt enzyme activity.
  • Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
  • Raf Assays Use biochemical, cell based or in vivo assays to measure Raf enzyme activity.
  • RAS Assays Use biochemical, cell based or in vivo assays to measure RAS enzyme activity.
  • Reversibility Study Determine whether or not a compound inhibits an enzyme reversibly.
  • Selectivity Profiling Determine the specificity of a ligand for its target by testing it against a large panel of related target proteins.
  • SELEX Select and identify highly specific aptamers with binding affinities comparable to traditional antibodies.
  • Sodium Channel Assays Use biochemical, cell-based or in vivo assays to measure sodium channel activity.
  • Solute-Linked Carrier (SLC) Transporter Inhibition Assays Use biochemical, cell-based or in vivo assays to measure solute-linked carrier transporter activity.
  • Solute-Linked Carrier (SLC) Transporter Substrate Identification Use biochemical, cell-based or in vivo assays to identify solute-linked carrier transporter substrates.
  • Substrate Competitive Study Determine whether or not a compound is competitive with a substrate.
  • Target Identification Identify the target(s) of a biologically active substance.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
  • Time Dependent Study Determine whether or not a compound binds to an enzyme in a time-dependent manner.
  • Transporter Assays Use biochemical, cell-based or in vitro assays to measure transporter target activity.
  • Ubiquitin Ligase Assays Measure ligase enzyme activity in the presence of cofactors or chemical modifiers.
  • UDP-glucuronosyltransferases (UGT) Inhibition Assays Use biochemical, cell-based or in vivo assays to measure UDP-glucuronosyltransferase activity.
  • Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Assays Use biochemical, cell based or in vivo assays to measure VEGF receptor activity.

In Vitro Toxicology

  • ADCC and CDC Assay Services Measure toxicity of antibodies.
  • HepaRG Cells Obtain terminally differentiated and cryopreserved hepatic cells that retain many characteristics of primary human hepatocytes.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
  • hERG Inhibition Measure the arrhythmia-producing potential of test compounds.

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Minipig Run pharmacokinetic studies in minipigs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
Show all 9 in In Vivo Pharmacokinetics 3 more
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.

Model Development

  • In Silico PK-PD Modeling Quantitative modeling and simulations correlation of pharmacokinetic and pharmacodynamic endpoints in support of preclinical and clinical development.

Oncology Models

  • 3D Triculture Breast Cancer Model Use tricultures of breast cancer cell lines, hMSCs, and endothelial tubules for evaluating breast cancer progression.

Protein Sciences

  • Carbohydrate Isolation Obtain pure monosaccharides, pure polysaccharides or related derivatives from samples.
  • Carbohydrate Isolation Protocol Development Design and optimize protocols for carbohydrate isolation.
  • Carbohydrate Structure Characterization Use analytical tools to elucidate carbohydrate structure and physiochemical properties.
  • Cytokines Find recombinant cytokines or cytokine assays.
  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
  • Enzymology Enzymology studies the biochemical activity, structure, and function of enzymes. Two key area of Enzymology are Cytochrome P450...
Show all 15 in Protein Sciences 9 more
  • Fluorescence Polarization Investigate receptor-ligand interactions, protein-DNA interactions, proteolysis and membrane fluidity.
  • Fluorophore Protein Conjugation Attach a fluorescent probe to a protein.
  • LCMS/MS Analysis Liquid chromatography–mass spectrometry is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry.
  • Peptide Synthesis Synthesize custom peptides that are long, have unusual modifications or are cyclic.
  • Protein Binding Determine drug-protein binding interactions
  • Solid Phase Peptide Synthesis Create peptides on solid supports with reduced product loss.
  • Surface Plasmon Resonance (SPR) Measure interactions of biomolecules including antibodies, vaccines, biomarkers and small molecules.
  • Western Blots Detect specific proteins in a sample of tissue homogenate or extract.
  • X-Ray Crystallography Elucidate structures of biological macromolecules such as proteins and nucleic acids.

Scientific Data Services

  • Data and Text Mining Derive structured data from free text in order to become accessible for data-mining algorithms.
  • Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)

Testing Services

  • In Vitro Skin Models Measure skin model penetration and invasion, photosensitivity and toxicity.
  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.

Other services

  • New Request  

Service areas:

Chemistry

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United Kingdom LOUGHBOROUGH, Loughborough 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Charnwood Molecular is a UK based CRO specialising in synthetic organic chemistry and we provide contract research, custom synthesis and discovery chemistry services:

  • Synthesis of building blocks, intermediates and reference standards
  • Medicinal Chemistry support
  • Synthetic route development and optimisation
  • Parallel synthesis capability - synthesis and purification of focused libraries
Professional associations
RSC
Website
www.charnwooddiscovery.com

Source: Scientist.com supplier network, written by the supplier

Get the Charnwood report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Charnwood on Scientist.com

For prices, more details, or to contact Charnwood, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.